Last Updated: 07/31/2014 01:19:41
JOEZ Stock Chart - 1 Month
JOEZ Stock Chart - 3 Month
JOEZ Stock Chart - 6 Month
JOEZ Stock Chart - 1 Year
JOEZ Stock Chart - 2 Year
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...
Continue Reading
New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...
Continue Reading
Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...
Continue Reading
Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...
Continue Reading
Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...
Continue Reading
Investor Insights into Novo Nordisk Options Trading In the dynamic landscape of stock trading, the behavior of high-value investors often reveals critical insights into future market movements. Recently, attention has shifted toward Novo Nordisk (NYSE: NVO), where wealthy investors have exhibited a notably bearish outlook. This significant trend is something that small...
Continue Reading
Insights from Ibex Medical Analytics on Cancer Diagnoses A recent survey has shed light on the fears and uncertainties many patients encounter when faced with potential cancer diagnoses. Ibex Medical Analytics, known for its innovative use of artificial intelligence (AI) in cancer diagnostics, identified key findings that highlight the emotions and perceptions of...
Continue Reading
OpenAI's Revolutionary Memory Deal In a significant move, OpenAI has established a preliminary agreement with major players in the tech industry, specifically South Korean giants Samsung Electronics Co Ltd and SK Hynix. This partnership is poised to reshape the landscape of artificial intelligence (AI) by addressing critical memory needs for AI systems. Significance of...
Continue Reading
Innovative Heat Pump Technology by Worksport's Terravis Energy Worksport Ltd. (NASDAQ: WKSP) is making significant strides in the clean technology space with its subsidiary Terravis Energy. This innovative company is focused on the development of cutting-edge heat pump technologies that are gaining attention in the multi-billion-dollar market. Exciting Partnership with...
Continue Reading
Ascom’s 2024 Financial Overview Ascom recently reported its financial results for 2024, showcasing a mix of challenges and opportunities for growth despite a declining revenue stream. The company's net revenue reached CHF 286.7 million, reflecting a decrease compared to the CHF 297.3 million achieved in 2023. This decline equates to a 1.6% decrease when looking at...
Continue Reading